BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21382045)

  • 1. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study.
    Pottgiesser T; Sottas PE; Echteler T; Robinson N; Umhau M; Schumacher YO
    Transfusion; 2011 Aug; 51(8):1707-15. PubMed ID: 21382045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemoglobin mass and biological passport for the detection of autologous blood doping.
    Pottgiesser T; Echteler T; Sottas PE; Umhau M; Schumacher YO
    Med Sci Sports Exerc; 2012 May; 44(5):835-43. PubMed ID: 21988933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers.
    Mørkeberg J; Sharpe K; Belhage B; Damsgaard R; Schmidt W; Prommer N; Gore CJ; Ashenden MJ
    Scand J Med Sci Sports; 2011 Apr; 21(2):235-43. PubMed ID: 19903320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hb mass measurement suitable to screen for illicit autologous blood transfusions.
    Pottgiesser T; Umhau M; Ahlgrim C; Ruthardt S; Roecker K; Schumacher YO
    Med Sci Sports Exerc; 2007 Oct; 39(10):1748-56. PubMed ID: 17909402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for autologous blood transfusions.
    Mørkeberg J; Belhage B; Ashenden M; Bornø A; Sharpe K; Dziegiel MH; Damsgaard R
    Int J Sports Med; 2009 Apr; 30(4):285-92. PubMed ID: 19199200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A third generation approach to detect erythropoietin abuse in athletes.
    Sharpe K; Ashenden MJ; Schumacher YO
    Haematologica; 2006 Mar; 91(3):356-63. PubMed ID: 16503554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulocyte and haemoglobin profiles in elite triathletes over four consecutive seasons.
    Díaz V; Lombardi G; Ricci C; Jacobs RA; Montalvo Z; Lundby C; Banfi G
    Int J Lab Hematol; 2011 Dec; 33(6):638-44. PubMed ID: 21707935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of growth hormone (GH)-dependent markers in the detection of GH abuse in sport: Physiological intra-individual variation of IGF-I, type 3 pro-collagen (P-III-P) and the GH-2000 detection score.
    Erotokritou-Mulligan I; Eryl Bassett E; Cowan DA; Bartlett C; Milward P; Sartorio A; Sönksen PH; Holt RI
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):520-6. PubMed ID: 19650783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of EPO doping and blood doping: the haematological module of the Athlete Biological Passport.
    Schumacher YO; Saugy M; Pottgiesser T; Robinson N
    Drug Test Anal; 2012 Nov; 4(11):846-53. PubMed ID: 22374784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of biological markers indicative of doping: the athlete biological passport.
    Saugy M; Lundby C; Robinson N
    Br J Sports Med; 2014 May; 48(10):827-32. PubMed ID: 24659506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A false start in the race against doping in sport: concerns with cycling's biological passport.
    Hailey N
    Duke Law J; 2011 Nov; 61(2):393-432. PubMed ID: 22069854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OMICS-strategies and methods in the fight against doping.
    Reichel C
    Forensic Sci Int; 2011 Dec; 213(1-3):20-34. PubMed ID: 21862249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case studies on ESA-doping as revealed by the Biological Passport.
    Zorzoli M; Rossi F
    Drug Test Anal; 2012 Nov; 4(11):854-8. PubMed ID: 22514122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of acute gastroenteritis on haematological markers used for the athletes biological passport - report of 5 cases.
    Schumacher YO; Pottgiesser T
    Int J Sports Med; 2011 Feb; 32(2):147-50. PubMed ID: 21110289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.